## Why Loss of alveolar surface area is right In emphysema, the combination of obstructive spirometry (FEV1/FVC <0.70) with reduced DLCO (<70% predicted) and reduced KCO is virtually pathognomonic for emphysema rather than other obstructive diseases. The marked **A** reduction in DLCO occurs because emphysema destroys alveolar walls and causes coalescence of air spaces, directly reducing the alveolar surface area available for gas exchange. This is the primary mechanism of DLCO reduction in emphysema, and the reduced KCO (DLCO/VA) confirms that the problem is not simply reduced alveolar volume but true loss of diffusing capacity per unit volume. Harrison 21e Ch 286 and ATS/ERS DLCO Standardisation 2017 establish that emphysema is distinguished from chronic bronchitis and asthma (which have normal DLCO) precisely by this pattern of obstructive spirometry + low DLCO + low KCO. ## Why each distractor is wrong - **Thickening of the alveolar-capillary membrane**: This is the primary mechanism of DLCO reduction in interstitial lung disease (IPF, hypersensitivity pneumonitis), not emphysema. ILD presents with a restrictive spirometry pattern (reduced TLC, normal or high FEV1/FVC), whereas this patient has obstructive spirometry. - **Reduced capillary blood volume**: While reduced capillary perfusion can lower DLCO, it is the hallmark of pulmonary vascular disease (CTEPH, PAH) and typically occurs with normal spirometry and reduced KCO. This patient's obstructive pattern with reduced KCO points to emphysema, not vascular disease. - **Anemia-induced reduction**: Although anemia does lower DLCO by reducing hemoglobin concentration, DLCO must be corrected for hemoglobin using the Cotes equation before clinical interpretation. Moreover, anemia would not explain the reduced KCO or the obstructive spirometry pattern in this smoker. **High-Yield:** The combination of reduced FEV1/FVC + reduced DLCO + reduced KCO = emphysema; reduced FEV1/FVC + normal DLCO = chronic bronchitis or asthma; restrictive pattern + reduced DLCO + preserved KCO = interstitial lung disease. [cite: Harrison 21e Ch 286; ATS/ERS DLCO Standardisation 2017]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.